| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥763.8B | ¥749.3B | +1.9% |
| Operating Income | ¥21.9B | ¥22.5B | -2.7% |
| Ordinary Income | ¥24.1B | ¥23.7B | +1.5% |
| Net Income | ¥14.2B | ¥14.5B | -2.4% |
| ROE | 7.6% | 8.0% | - |
FY2026 Q3 cumulative results show Revenue of 763.8B yen (YoY +1.9%), Operating Income of 21.9B yen (YoY -2.7%), Ordinary Income of 24.1B yen (YoY +1.5%), and Net Income of 14.2B yen (YoY -2.4%). The company achieved modest top-line growth but experienced slight profit contraction, representing a "revenue up/profit down" pattern. Operating margin compressed to 2.9% from 3.0% in the prior year, while net profit margin stood at 1.9%. The company maintains substantial cash reserves of 300.2B yen against total assets of 520.6B yen, providing strong liquidity cushion. Despite revenue growth, profitability remains pressured by elevated SG&A expenses of 172.6B yen representing 22.6% of revenue, which exceeded gross margin expansion capacity.
Revenue increased 14.5B yen (+1.9% YoY) to 763.8B yen, driven primarily by growth in the HumanResource segment which expanded 7.6B yen to 455.9B yen. The Education segment grew modestly by 0.4B yen to 194.2B yen (+0.2% YoY), while the Care segment increased 4.1B yen to 97.1B yen (+4.4% YoY). Segment commentary notes that the IT business previously classified under "Other" was merged into HumanResource effective March 1, 2025, following the absorption of Human Digital Consultants into Human Resocia, contributing to HumanResource's revenue consolidation. The Other segment grew 2.5B yen to 18.1B yen, reflecting expansion in sports and nail salon operations.
On the profit side, Operating Income declined 0.6B yen (-2.7% YoY) to 21.9B yen despite revenue growth. Cost of Sales increased 16.3B yen to 569.4B yen, resulting in Gross Profit of 194.4B yen at a 25.5% margin, essentially flat from prior year's 25.6%. The primary profit headwind came from SG&A expenses rising 15.1B yen to 172.6B yen, absorbing most of the gross profit gain and leaving operating leverage negative. The company recorded non-recurring extraordinary losses of 1.3B yen, including impairment losses of 0.3B yen related to underperforming Care segment facilities and 0.1B yen in disposal losses from office relocations and business transfers across HumanResource, Education, and Other segments.
Ordinary Income improved 0.4B yen (+1.5% YoY) to 24.1B yen, benefiting from net non-operating income of 2.2B yen comprising 3.1B yen in non-operating income (primarily 0.3B yen interest income and 0.9B yen other income) offset by 0.8B yen in non-operating expenses (0.5B yen interest expense and 0.3B yen other expenses). The gap between Ordinary Income (24.1B yen) and Operating Income (21.9B yen) of 2.2B yen represents 9.1% of Operating Income, within the materiality threshold but indicating meaningful contribution from financial activities. Net Income of 14.2B yen reflects an effective tax rate of 38.0% on Profit Before Tax of 22.8B yen, with tax burden reducing net income by 8.7B yen.
This represents a "revenue up/profit down" performance pattern, where top-line growth of 1.9% was insufficient to overcome operating expense inflation and tax burden, resulting in operating and net profit contractions of 2.7% and 2.4% respectively.
The HumanResource segment is the core business, generating 455.9B yen in revenue (59.7% of total) and 19.2B yen in operating income at a 4.2% margin. Segment profit increased 1.2B yen (+6.5% YoY) from 18.1B yen, demonstrating improving operational efficiency. This segment absorbed the IT business during the period, contributing to both revenue and profit consolidation.
The Education segment produced 194.2B yen in revenue (25.4% of total) but only 0.1B yen in operating income, representing a 0.1% margin. Operating profit collapsed 2.6B yen from 2.8B yen in the prior year, indicating severe profitability deterioration. Segment notes indicate impairment losses of 48.1M yen were recorded for facilities undergoing relocation or transfer.
The Care segment generated 97.1B yen in revenue (12.7% of total) with 2.6B yen in operating income at a 2.7% margin. Operating profit increased 0.6B yen (+28.8% YoY) from 2.0B yen, showing strong margin improvement. However, the segment recorded 280.1M yen in impairment losses during the period for underperforming facilities with persistently negative cash flows.
Margin disparity is material, with HumanResource at 4.2% significantly outperforming Education at 0.1% and Care at 2.7%. The Education segment's margin collapse from 14.6% prior year to near-zero warrants particular attention as a key profitability risk.
[Profitability] ROE of 7.6% remains below industry standards and reflects compressed returns on shareholder capital. Operating margin of 2.9% declined from 3.0% YoY, indicating negative operating leverage as SG&A expense growth (22.6% of revenue) outpaced gross margin capacity (25.5%). Net profit margin of 1.9% reflects heavy tax burden at 38.0% effective rate and elevated SG&A absorption. DuPont analysis reveals ROE of 7.5% driven by net profit margin 1.9%, asset turnover 1.467, and financial leverage 2.78x, with profitability being the primary constraint rather than asset efficiency or capital structure. Interest coverage ratio stands at 42.31x (Operating Income 21.9B yen / Interest Expense 0.5B yen), indicating minimal financial risk from debt service. [Cash Quality] Cash and deposits of 300.2B yen provide 1.22x coverage of current liabilities (246.2B yen) and 4.22x coverage of interest-bearing debt (71.2B yen), demonstrating substantial liquidity reserves. [Investment Efficiency] Asset turnover of 1.467 (Revenue 763.8B yen / Total Assets 520.6B yen) exceeds industry norms and reflects efficient asset utilization, particularly given the high cash balance reducing denominator efficiency. Inventory turnover of 109.5 (Cost of Sales 569.4B yen / Inventories 5.2B yen) is exceptionally high, consistent with service-oriented business model with minimal physical inventory. [Financial Health] Equity ratio of 36.0% (Total Equity 187.3B yen / Total Assets 520.6B yen) reflects moderate financial stability, while current ratio of 174.8% (Current Assets 430.4B yen / Current Liabilities 246.2B yen) indicates strong short-term solvency. Debt-to-equity ratio of 0.38 (Long-term Loans 71.2B yen / Total Equity 187.3B yen) represents conservative leverage with debt-to-capital ratio of 27.5%.
Cash and deposits increased 41.1B yen YoY to 300.2B yen, reflecting strong cash accumulation despite profit headwinds. Trade receivables decreased 8.3B yen to 110.0B yen, improving working capital efficiency and potentially accelerating cash collection cycles. Trade payables increased 0.6B yen to 1.8B yen, though the absolute level remains minimal relative to business scale, suggesting limited reliance on supplier credit. Total equity increased 6.3B yen to 187.3B yen, with retained earnings growing to 166.7B yen as profits were partially retained after dividend distributions. The balance sheet demonstrates substantial deleveraging capacity with current liabilities coverage of 1.22x from cash alone, indicating the company could theoretically settle all short-term obligations while retaining 54.0B yen in cash reserves. Contract liabilities of 76.9B yen represent advance payments and deferred revenue, providing forward visibility into revenue recognition in subsequent periods. The increase in total assets of 13.2B yen was primarily allocated to cash accumulation (41.1B yen increase) partially offset by working capital optimization (receivables reduction).
Ordinary Income of 24.1B yen versus Operating Income of 21.9B yen shows net non-operating contribution of 2.2B yen, representing 9.1% of operating income. This comprises non-operating income of 3.1B yen (primarily 0.3B yen interest income and 0.9B yen other income) less non-operating expenses of 0.8B yen (0.5B yen interest expense and 0.3B yen other expenses). Non-operating income represents 0.4% of revenue (3.1B yen / 763.8B yen), indicating minimal dependency on non-core activities for profitability. Extraordinary losses of 1.3B yen include 0.3B yen impairment losses and 0.1B yen disposal losses, representing non-recurring charges from facility restructuring and business transfers. These impairments are concentrated in the Care segment (280.1M yen) and Other segment (6.6M yen), suggesting ongoing portfolio optimization. The absence of operating cash flow data limits assessment of accruals quality, but the substantial cash accumulation (41.1B yen increase) relative to net income (14.2B yen) suggests positive cash conversion, though this may reflect working capital timing rather than sustainable operating cash generation. The effective tax rate of 38.0% is elevated relative to statutory rates, warranting examination of non-deductible expenses or tax jurisdiction mix effects.
Q3 cumulative progress against full-year guidance shows Revenue at 73.7% (763.8B yen / 1,036.0B yen), Operating Income at 60.8% (21.9B yen / 36.0B yen), Ordinary Income at 65.1% (24.1B yen / 37.0B yen), and Net Income at 56.6% (14.2B yen / 25.0B yen). Revenue progress of 73.7% against the standard 75.0% benchmark for Q3 indicates slight underperformance of 1.3 percentage points, suggesting potential headwinds to achieving full-year top-line targets without Q4 acceleration. Operating Income progress of 60.8% trails the 75.0% benchmark by 14.2 percentage points, representing material shortfall requiring significant Q4 profit delivery. The company requires 14.1B yen in Q4 Operating Income to meet guidance, representing 64.4% of cumulative Q3 operating income and implying historically strong seasonality or operational improvements not yet visible. Net Income progress of 56.6% indicates required Q4 net income of 10.8B yen, representing 76.2% of cumulative Q3 net income. No forecast revision was announced this quarter, maintaining original guidance despite mid-year underperformance. Forecast notes indicate assumptions are subject to uncertainty and reference supplemental materials published February 13, 2026 for detailed premise disclosure. The company's contract liabilities of 76.9B yen represent 10.1% of annual revenue guidance (1,036.0B yen), providing 1.2 months of forward revenue visibility based on deferred income recognition, indicating moderate contractual backlog supporting near-term revenue stability.
The company forecasts an annual dividend of 72.50 yen per share for the full fiscal year, with no interim dividend paid in Q2 (0 yen) and year-end dividend expected at 72.50 yen. Based on forecast EPS of 240.90 yen and dividend of 72.50 yen, the payout ratio is projected at 30.1%. However, based on Q3 cumulative Basic EPS of 136.38 yen, if year-end dividend of 75.50 yen is paid as reported in balance sheet data, the calculated payout ratio against trailing nine-month earnings would be 55.4% (75.50 yen / 136.38 yen), reflecting elevated distribution relative to achieved earnings. Cash reserves of 300.2B yen provide substantial capacity to sustain dividends with coverage of 41.4x the projected full-year dividend payment of 7.25B yen (72.50 yen x 10.378M shares). No share buyback activity was disclosed during the period. The dividend policy appears shareholder-friendly with payout ratio in the 30-55% range depending on full-year earnings achievement, balancing return of capital with retention for growth investment. Dividend sustainability is supported by strong cash position, though reliance on balance sheet cash rather than operating cash flow generation for distributions warrants monitoring if profitability remains constrained.
Labor market volatility and wage inflation in the HumanResource segment pose material risk, as this core business (59.7% of revenue) depends on staffing supply-demand balance and faces upward pressure on personnel costs that may compress the 4.2% operating margin if not offset by pricing power or operational efficiency gains. Education segment profitability deterioration represents acute concern, with operating margin collapsing from 14.6% prior year to 0.1% current period despite stable revenue, indicating structural cost inflation or pricing pressure that requires immediate management intervention to prevent sustained losses. Impairment risk across Care and Other segments continues, with 308.7M yen in asset write-downs during Q3 for underperforming facilities, suggesting ongoing portfolio rationalization that may generate additional non-recurring charges and signal underlying business model challenges in certain operations requiring strategic reassessment or divestiture consideration.
[Industry Position] (Reference - Proprietary Analysis)
The company's financial profile shows material divergence from IT/Telecom industry medians. Profitability metrics significantly trail industry benchmarks: ROE of 7.6% versus industry median of 8.3% (2025-Q3, n=104), placing the company below median despite comparable financial leverage of 2.78x versus industry median 1.66x. Operating margin of 2.9% substantially underperforms industry median of 8.2% (IQR: 3.6%-18.0%), indicating severe operating efficiency challenges relative to peers. Net profit margin of 1.9% falls well below industry median of 6.0% (IQR: 2.2%-12.7%), reflecting both operating margin weakness and elevated tax burden. Return on Assets of 2.7% (calculated as Net Income 14.2B / Total Assets 520.6B) trails industry median of 3.9% (IQR: 1.4%-7.0%).
Revenue growth of 1.9% YoY lags industry median growth of 10.4% (IQR: -1.2%-19.6%), suggesting market share loss or exposure to slower-growth verticals within the broader industry. Asset turnover of 1.467 significantly exceeds industry median of 0.67 (IQR: 0.49-0.93), representing a key operational strength in asset-light service delivery model. Financial health metrics show mixed positioning: Equity ratio of 36.0% trails industry median of 59.2% (IQR: 42.5%-72.7%), indicating more aggressive capital structure, while current ratio of 174.8% (1.75x) falls below industry median of 2.15x (IQR: 1.57x-3.62x) despite absolute liquidity strength.
The company's receivables turnover of 52.4 days (Trade Receivables 110.0B / Revenue 763.8B x 365/9 x 12/9) compares favorably to industry median of 61.25 days (IQR: 45.96-82.69), indicating efficient collection practices. However, payables turnover of only 1.2 days (Trade Payables 1.8B / Cost of Sales 569.4B x 365/9 x 12/9) dramatically underperforms industry median of 34.69 days (IQR: 20.68-57.74), suggesting minimal supplier credit utilization and potential working capital optimization opportunity.
(Industry: IT & Telecom (104 companies), Comparison: 2025-Q3 period, Source: Proprietary Analysis)
Structural profitability challenge persists with operating margin of 2.9% well below industry median of 8.2%, driven by SG&A expense ratio of 22.6% that constrains earnings leverage despite solid 25.5% gross margin, requiring strategic cost restructuring or business mix shift toward higher-margin services to achieve industry-comparable returns on equity. Education segment margin collapse from 14.6% to 0.1% represents acute profit deterioration concentrated in the second-largest business (25.4% of revenue), signaling either cyclical enrollment pressure or structural cost inflation that management must address through pricing actions, cost realignment, or potential strategic review to prevent this segment from becoming a sustained drag on consolidated profitability. Balance sheet fortress provides strategic optionality with cash reserves of 300.2B yen (57.7% of total assets) and conservative debt-to-equity of 0.38, enabling management to pursue M&A for margin-accretive businesses, weather economic downturns, or sustain elevated shareholder distributions, though current deployment toward low-yielding cash rather than growth investment or debt reduction suggests capital allocation requires strategic clarity to optimize returns.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.